Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $25M | $32.8M | $37.7M | $7.6M | $10.4M | |
| Gross Profit | $7.8M | $13.8M | $16.6M | $2.5M | $4.7M | |
| Operating Income | -$30.3M | -$24.4M | -$18.5M | -$6.1M | -$3.1M | |
| EBITDA | -$15.7M | -$8.9M | -$1.7M | -$1.9M | $1.3M | |
| Diluted EPS | -$0.94 | -$0.08 | -$0.49 | -$0.14 | -$0.09 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $43.9M | $16.2M | $22.8M | $22.4M | $25.3M | |
| Total Assets | $133.4M | $161.8M | $162.4M | $182.4M | $192.1M | |
| Current Liabilities | $8.4M | $14M | $11.8M | $14.8M | $16.4M | |
| Total Liabilities | $15.6M | $28.4M | $24.3M | $27.8M | $47.3M | |
| Total Equity | $117.9M | $133.4M | $138.1M | $154.5M | $144.8M | |
| Total Debt | $19.1K | $289.8K | $109.4K | $1.3M | $16.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$14.2M | -$11.5M | -$5.9M | -$3.6M | -$1.4M | |
| Cash From Investing | -$9M | -$9.5M | -$10.9M | -$2.6M | -$2.7M | |
| Cash From Financing | $27.9M | $13.4M | $15M | -$300 | $5.4M | |
| Free Cash Flow | -$23.2M | -$21.1M | -$16.8M | -$6.1M | -$4M | |
Smart Eye AB engages in the development of artificial intelligence in the form of eye tracking technology. It operates through the following business areas: Research Instruments, Automotive Solutions, and Applied AI Systems. The Research Instruments business area focuses on advanced eye tracking systems for measuring and analyzing human behavior. The Automotive Solutions business area provides eye tracking software for integration in cars and other vehicles. The Applied AI Systems business area provides software and hardware for retrofit in vehicles. The company was founded by Nils Martin Krantz and Mats Stefan Krantz in 1999 and is headquartered in Gothenburg, Sweden.
In the current month, SMTEF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMTEF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Smart Eye AB share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Smart Eye AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smart Eye AB is a Sell and believe this share price will rise from its current level to --.
The price target for Smart Eye AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Smart Eye AB is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Smart Eye AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smart Eye AB shares.
Smart Eye AB was last trading at $8.00 per share. This represents the most recent stock quote for Smart Eye AB. Yesterday, Smart Eye AB closed at $8.00 per share.
In order to purchase Smart Eye AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.